Summary & Overview
CPT 69726: Bone-Anchored Hearing Implant Explantation
CPT code 69726 designates surgical removal of a bone-anchored auditory implant that is directly coupled to a speech processor via a percutaneous skin opening. This procedure is relevant to otologic and neurotologic surgical practices and to payers managing coverage for hearing implant therapies and device lifecycle events. Nationally, explantation codes like 69726 matter for utilization tracking, device management policies, and coverage criteria for implantable hearing solutions.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for device explantation, typical sites of service, and the common modifiers associated with this surgical service. The publication outlines benchmarks and billing considerations relevant to hospital and ambulatory surgical center settings and summarizes policy and coding issues that affect reimbursement and claims adjudication nationally.
The report is intended to inform billing staff, clinicians, and policy analysts about the clinical definition and coding scope of 69726, payer coverage landscape, and areas where coding clarity influences payment and utilization monitoring. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 69726 describes the removal of a bone-anchored auditory implant that converts sound energy for reception by the inner ear. The procedure involves explantation of an implant that is coupled directly to a speech processor percutaneously through a small opening in the skin.
-
Service type: Surgical explantation of a percutaneous bone-anchored hearing device
-
Typical site of service: Hospital operating room or ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A patient with a percutaneous bone-anchored hearing implant (BAHI) presents for removal of the abutment and implant hardware due to chronic infection at the skin-implant interface and persistent pain unresponsive to conservative management. The typical workflow begins with preoperative evaluation by the otolaryngologist and audiologist, documentation of failed conservative care (topical/systemic antibiotics, local wound care), and discussion of removal alternatives. Pre-op testing includes standard labs as indicated, anesthesia evaluation (local with sedation or general anesthesia depending on patient factors), and informed consent. In the operating room or procedure suite the surgeon confirms laterality, documents intraoperative findings (eg, granulation tissue, peri-implant osteomyelitis), removes the percutaneous implant and abutment, irrigates the site, obtains cultures if infection is present, and closes or leaves the site to heal by secondary intention per clinical judgment. Postoperative care includes wound care instructions, pain control, possible oral antibiotics based on culture results, and arranging follow-up for wound assessment and future auditory rehabilitation planning (contralateral hearing device or re-implantation options). Typical site of service is an ambulatory surgical center or hospital outpatient department; minor cases may be done in a procedure suite depending on anesthesia needs. Service type: surgical removal of a percutaneous bone-anchored hearing device (explantation of bone-anchored implant). Typical patient: adult or pediatric patient with chronic periabutment infection, implant extrusion, pain, or device failure requiring removal of the percutaneous coupling to the speech processor.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|